Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Metabolic interactions in the vascular wall: an integrated experimental and computational approach

Award Number: R01HL165193
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2023
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

Metabolic interactions in the vascular wall: an integrated experimental and computational approach - Project Summary Nearly 1 in 3 American adults has metabolic syndrome, a complex disorder defined by elevations in blood sugar, cholesterol, and triglycerides. Patients with metabolic syndrome have a high cardiovascular disease risk due to interactions among the elevated blood metabolites. However, since we do not have good methods for studying integrated and interacting metabolic changes, we treat each metabolic abnormality individually. As a result, patients are often on multiple medications, potentially decreasing the ability of each drug to normalize blood metabolites and raising the risk for negative drug interactions. In this project, we propose a novel integrated experimental and computational bioengineering approach to study how metabolic abnormalities contribute to cardiovascular disease. Specifically, we will study metabolic interactions between endothelial cells, which line the inside of the blood vessels, and vascular smooth muscle cells, which contribute to cardiovascular disease when they change their function. We will engineer a computational isotope-assisted metabolic flux analysis (iMFA) model, which uses experimental mass spectrometry data to estimate intracellular metabolic fluxes and metabolite transport. The computational model will enable us to develop new hypotheses for and plan studies into how metabolic changes (from altered blood metabolites or therapies) affect the vascular wall. We hypothesize that EC metabolic dysfunction increases the transport of metabolites that promote VSMC to switch from a contractile to a synthetic phenotype. In turn, synthetic vSMC enhance EC metabolite transport to support proliferation. To explore this hypothesis, we will combine in vitro, in silico, and ex vivo studies to: 1) Determine how EC dysfunction in altered metabolic environments impacts metabolite transport; 2) Measure how altered metabolites synergistically shift vSMC to a synthetic phenotype; and 3) Investigate how EC-vSMC crosstalk impacts cell metabolism and phenotype in the vascular wall. We will start with single cell models of endothelial and vascular smooth muscle cells, which will simulate the diversity of human nutrient levels. We will the integrate the two cell types to understand their crosstalk in vitro, in silico, and ex vivo. At each step, we will relate metabolism to cell phenotype and function to link the model to cardiovascular disease. The computational iMFA model of integrated endothelial-vascular smooth muscle cell metabolism, transport, and function will enable us to develop new hypotheses for and plan studies into how metabolic changes from altered blood metabolites or therapies affect the vascular wall. By changing the parenchymal cell type, the model can then be extended to study vascular metabolic interactions in other tissues (e.g., brain) and shed light into other diseases in which integrated EC metabolism and transport (e.g., Alzheimer’s disease).


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $729,600 )
2026	2026	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BUILDING	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Cardiovascular Diseases Research	000	4	4/20/2026	NON-COMPETING CONTINUATION	$729,600
														Subtotal = $729,600

Issue Date FY: 2025 ( Subtotal = $744,490 )
2025	2025	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BUILDING	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Cardiovascular Diseases Research	000	3	4/3/2025	NON-COMPETING CONTINUATION	$670,041
2025	2025	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BUILDING	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Cardiovascular Diseases Research	001	3	7/9/2025	NON-COMPETING CONTINUATION	$74,449
														Subtotal = $744,490

Issue Date FY: 2024 ( Subtotal = $729,600 )
2024	2024	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BUILDING	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Cardiovascular Diseases Research	001	2	6/21/2024	NON-COMPETING CONTINUATION	$59,559
2024	2024	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BUILDING	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Cardiovascular Diseases Research	000	2	3/29/2024	NON-COMPETING CONTINUATION	$670,041
														Subtotal = $729,600

Issue Date FY: 2023 ( Subtotal = $743,708 )
2023	2023	UNIVERSITY OF MARYLAND, COLLEGE PARK	3112 LEE BLDG 7809 REGENTS DR	COLLEGE PARK	MD	20742	PRINCE GEORGES	USA	Cardiovascular Diseases Research	000	1	4/7/2023	NEW	$743,708
														Subtotal = $743,708

Grand Total All Awards = $2,947,398

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Metabolic interactions in the vascular wall: an integrated experimental and computational approach

Award Number: R01HL165193

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2023

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer